• Home
  • Study Details
Open

SPECT-CT Guided Elective Contralateral Neck Treatment for Pts With Lateralized Oropharyngeal Cancer

To determine if a lymphatic mapping-guided approach (experimental arm) for management of the contralateral neck has a non-inferior disease-free survival (DFS) compared to bilateral neck radiation therapy RT (control arm) in patients with lateralized Oropharyngeal Cancer (OPC) not involving or crossing the midline and without clinical contralateral nodal disease.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments

Location

North Carolina

What will be asked of you

Have you been diagnosed with Lateralized Oropharyngeal Cancer . If so, you may be able to take part in a research study looking at the safety by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT) compared to the usual treatment when radiotherapy is given . The study involves randomization (selection by 50/50 chance to assigned group), blood collection for research purposes in addition to routine blood work, diagnostic imaging scan (ex: MRI/SPET/PET/CT Scan) and study questionnaires so that there is a understanding of your care and needs as a patient.

In-person visits:
approximately ~20
Total length of participation:
84 months

Looking for Specific Volunteers

Able to participate:

  • Must have a diagnosis of lateralized (one-sided) oropharyngeal squamous cell carcinoma (OPC)
  • Must be at least 18 years of age

Not eligible if:

  • Chronic Obstructive Pulmonary Disease (COPD)or other lung related illness requiring hospitalization within the last 30 days
  • Unstable angina and/or congestive heart failure requiring hospitalization within the last 30 days
  • Acute myocardial infarction (heart attack) within the last 30

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Xuguang Chen
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Head and Neck)

IRB Number

23-2845

ClinicalTrials.gov

NCT05451004

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research